基本資料
種類: ETF
費用比率%: 0.80
資產淨值: 30.92
成立日期: 16/11/2022
 
分析
市值分佈:
87.48%
大市值
3.12%
中市值
0.61%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 32  
0%
 
100%
     10大 (66.28%)
代號 名稱 佔比% 持有日期
LLYEli Lilly & Co19.8728/02/2026
ASNDAscendis Pharma A/S16.1928/02/2026
ABBVABBVIE7.4728/02/2026
PCVXVaxcyte4.7028/02/2026
LEGNLegend Biotech Corp3.6528/02/2026
DHRDanaher Corp3.0528/02/2026
RYTMRhythm Pharmaceuticals3.0128/02/2026
NTRANatera2.8028/02/2026
ABVXAbivax SA2.7828/02/2026
RVMDRevolution Medicines2.7528/02/2026
ADMAADMA Biologics2.5528/02/2026
CORCencora2.4528/02/2026
IDXXIDEXX Laboratories2.0228/02/2026
WGSGeneDx Holdings Corp2.0028/02/2026
PODDInsulet Corp1.4628/02/2026
NVONovo-Nordisk A/S1.4228/02/2026
TECHBio-Techne Corp1.3528/02/2026
UNHUnitedhealth Group1.3128/02/2026
ADPTAdaptive Biotechnologies Corp1.1328/02/2026
ALNYAlnylam Pharmaceuticals1.1028/02/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.